Jump to Navigation
Home
News
Daily News
Documents
Health Insider
Abortion Roundup
Special Opioid Report
Topics
Biden Health Agenda
Election 2024
AI
Coronavirus
Abortion
Health Equity
Health Reform Debate
Opioids
Medicaid
Medicare
Rx Drugs
Medical Devices
Congress
ACOs
Emergency Response
The Courts
21st Century Cures
Budget
Cybersecurity
Food Safety
Tobacco
User Fees
Waste and Fraud
FDA Week
Inside CMS
Inside Drug Pricing
Latest News
Documents
Health Exchange Alert
Latest News
Documents
Inside TeleHealth
About Us
About Us
Privacy Policy
Terms and Conditions
Login Help
Saturday, May 4, 2024
/index.php?option=com_iwpfile&file=/dir_04/he2004_0206.pdf
/index.php?option=com_iwpfile&file=/dir_04/he2004_0205.pdf
/index.php?option=com_iwpfile&file=/dir_04/he2004_0204.pdf
Overview Memorandum
Bibliography
Background Memorandum
Prozac Label
Pediatric Program Summary Statistics
Daschle Blames Medicare Drug Bill Costs On Overpayments To Drug Companies And HMO Giveaways
House Minority Leader Pelosi Accuses President Of Misleading Seniors With Medicare Bill
Rep.
/index.php?option=com_iwpfile&file=/dir_04/he2004_0201.pdf
/index.php?option=com_iwpfile&file=/dir_04/he2004_0200.pdf
/index.php?option=com_iwpfile&file=/dir_04/he2004_0199.pdf
/index.php?option=com_iwpfile&file=/dir_04/he2004_0198.pdf
APA FDA Drug Blitz
Public Safety Is At Risk With Foreign Drug Importation
Statement By Craig Fuller
Pages
« first
‹ previous
…
6084
6085
6086
6087
6088
6089
6090
6091
6092
…
next ›
last »
Log in to access this content.
Username
*
Password
*
Remember me
Not a subscriber?
Sign up for 30 days free access
to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.